Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial

Show other versions (2)
Bibliographic Details
Main Authors: Borthwick, N, Ahmed, T, Rose, A, Ebrahimsa, U, Black, A, Hayton, E, Yang, H, Hancock, G, Campion, S, Frahm, N, Colloca, S, Nicosia, A, McMichael, A, Dorrell, L, Hanke, T
Format: Journal article
Published: 2012

Similar Items